Law Office of Brodsky & Smith, LLC Announces Investigation of Arch Chemicals, Inc.
14 Julho 2011 - 1:06PM
Business Wire
Law office of Brodsky & Smith, LLC announces that it is
investigating potential claims against the Board of Directors of
Arch Chemicals, Inc. (“Arch” or the “Company”) (NYSE: ARJ)
relating to the proposed acquisition by Lonza Group Ltd., Inc.
(“Lonza”).
Under the terms of the offer, Arch shareholders would receive
$47.20 in cash for each share of Arch common stock they own. The
investigation concerns possible breaches of fiduciary duty and
other violations of state law by the Board of Directors of Arch for
not acting in Arch shareholders' best interests in connection with
the sale process to Lonza. The transaction appears to be unfair, in
part, given Arch’s recent positive results. Arch reported first
quarter results that exceed analyst expectations. On May 3, 2011,
Arch reported $325.5 million in revenue for the quarter. This
represented a 9% increase over the same quarter in the previous
year.
If you own shares of Arch and wish to discuss the legal
ramifications of the proposed transaction, or have any questions,
you may e-mail or call the law office of Brodsky & Smith, LLC
who will, without obligation or cost to you, attempt to answer your
questions. You may contact Jason L. Brodsky, Esquire or Evan J.
Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite
602, Bala Cynwyd, PA 19004, by e-mail at
investorrelations@brodsky-smith.com, visiting
http://brodsky-smith.com/313-arj-arch-chemicals-inc.html, or by
calling toll free 877-LEGAL-90.
Arch Chemicals (NYSE:ARJ)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Arch Chemicals (NYSE:ARJ)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024
Notícias em tempo-real sobre Arch Chemicals da New York Stock Exchange bolsa de valores: 0 artigos recentes
Mais Notícias de Brodsky & Smith, LLC